Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Hot Flashes”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources

[Hot flashes resistant to hormone replacement in menopausal women: panic disorder?].

Of two women aged 52 and 49, the first one was treated with increasingly high doses of oestrogens to reduce menopausal complaints and the second suffered from menopausal complaints while receiving antiepileptic treatment following surgical removal of a meningioma. The women had hot flushes refractive to hormone supplementation. The first one even developed addictive symptoms, demanding more and more hormone supplementation from her gynaecologist as her symptoms would not subside. Ultimately a panic disorder was diagnosed in both women. Symptoms of panic disorder can be disguised as or comorbid with menopausal complaints such as hot flushes. As patients with these complaints present themselves generally to their general practitioner or gynaecologist, the panic disorder may easily be overlooked. Both women reacted well to reattribution of their complaints, explanation that they had developed a panic disorder, behaviour therapy and treatment with clomipramine. Clues for diagnosis are lack of reaction to hormonal supplementation, worsening of symptoms after hormonal supplementation, as well as a positive history for anxiety symptoms and somatizing behaviour.

Behavior Therapy↗

Hot flashes.

CASE STUDY: Mr. J is a 68-year-old African American man with a history of advanced prostate cancer. He was diagnosed nine months prior with adenocarcinoma of the prostate, with a Gleason score of 9 and tumor, node, metastasis staging of T3 NO M1. His prostate-specific antigen (PSA) was 483 ng/ml at the time of diagnosis. He immediately began treatment with total androgen blockade after the staging workup was completed.

Adenocarcinoma↗

Hot flashes and estrogen therapy do not influence cognition in early menopausal women.

OBJECTIVE: To examine how menopausal symptoms and estrogen therapy (ET)-induced symptom relief affect cognition in early menopause. DESIGN: There were two components. Part 1 was a cross-sectional study of 37 healthy, recently postmenopausal women with diverse menopausal symptoms. Women were categorized as having low (n=20) or high symptoms (n=17) based on a validated symptom questionnaire. Women completed mood and sleep questionnaires and underwent cognitive testing, which included verbal memory, visual memory, emotional memory, and verbal fluency. Thirty-two of these women went on to part 2 of the study. Fourteen were randomly assigned to receive ET and 18 to receive placebo for 8 weeks. Before treatment and at 4 and 8 weeks, women completed the same measures as in part 1 of the study. RESULTS: High symptom women had more negative mood (P=0.01) and lower quality sleep (P<0.001) than low symptom women. Despite suffering from more menopausal symptoms, worse mood, and poorer sleep, women in the high symptom group performed the same on cognitive testing as women in the low symptom group. Women receiving ET had greater improvements in menopausal symptoms and sleep compared with those receiving the placebo (P<or=0.05). ET did not improve mood compared with placebo. Women receiving ET did not have any improvement in cognitive performance compared with those receiving the placebo. CONCLUSIONS: Menopausal symptoms do not impair cognition. ET does not improve cognition despite alleviating symptoms and improving sleep in recently naturally menopausal women with diverse menopausal symptoms.

Cognition↗

[Hot flashes after orchiectomy in treatment of prostate cancer-- a serious side effect].

Orchiectomy is a frequently performed therapy for prostatic carcinoma in elderly men. A so far widely neglected side-effect is the occurrence of hot flushes. They considerably decrease the quality of life of a large number of the patients who often are in a palliative situation and handicapped by other diseases. Therapeutic options are widely unknown. Therefore, the patients often consult their doctors in vain. In a study with 32 patients clinical appearance of hot flushes and their effects on the patient's quality of life were analyzed. 69% of patients with a mean age of 75 years experienced hot flushes, whereas 31% of patients with a mean age of 80 years had not been bothered by hot flushes. Possible therapeutic options are presented and discussed. Ciproteronacetate seems to be the most effective therapy with the least side-effects (9).

Aged↗

[The treatment of hot flashes due to menopause. Comparative study of two drugs (author's transl)].

The efficacy of veralipride, a new non-hormonal treatment for the treatment of menopausal symptoms, was evaluated following a randomised comparative study with a commonly used non-hormonal drug, bêta-alanine. Two groups of patients between 53 and 59 years received, one veralipride (22) at a dose of 100 mg/day for 20 days, the other beta-alanine (21) during the same period. 14 patients noted an improvement in their hot flushes while receiving veralipride as against 4 receiving beta-alanine. The superiority of veralipride was quite significant (P less than 0.01). Both products were well tolerated.

Adult↗

Treating hot flashes.

Explore the source record for details and available documents.

Adrenergic alpha-Agonists↗